IP Library Granted Patent US 8,622,991
Granted Patent B2
US 8,622,991 · App. 12/450,246 · Granted Jan 7, 2014

Method and device for drug delivery

Inventors: Benny Pesach (Rosh-ha ayin, IL); Gabriel Bitton (Jerusalem, IL); Ram Weiss (Haifa, IL); Ron Nagar (Tel Aviv, IL)
Assignee: Insuline Medical Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,622,991
App. No.
12/450,246
Granted
Jan 7, 2014
Kind
B2
Abstract

Systems, devices and methods for delivery of a chemical substance to the body of the patient are provided. Such embodiments may include an infusion catheter configured to be inserted into tissue, a catheter securing element configured to be adhered to the skin of the patient and further configured to secure the infusion catheter to the skin, a drug delivery pump configured to infuse a drug into the infusion catheter for delivery to a drug infused region on the body of the patient, and a treatment element configured to apply a treatment to the drug infused region to improve pharmacodynamics of the drug during a period of delivery of the drug to the patient.

Claims (46)

1. A device for delivering a therapeutic substance into the body of a patient, comprising:

an infusion catheter configured to be inserted into a bodily tissue disposed at an insertion site located on the body of the patient and further configured to deliver the therapeutic substance into the body of the patient to an infused region, wherein the infused region includes a volume of the bodily tissue surrounding the insertion site;

a catheter securing element configured to be adhered to the skin of the patient and further configured to secure the infusion catheter to the skin of the patient;

a housing including

a substance delivery device for infusing the therapeutic substance into the infusion catheter for delivery of the therapeutic substance into the infused region;

a sensor built into the housing and configured to detect infusion of the therapeutic substance;

a treatment element configured to apply a treatment in a vicinity of the infused region to modify a pharmacokinetic and/or pharmacodynamic profile of the therapeutic substance; and

a controller unit in communication with the treatment element and configured to initiate application of the treatment by the treatment element upon detecting beginning of the infusion of the therapeutic substance.

2. The device according to claim 1 , wherein the treatment is applied at a time selected from a group consisting of: before the therapeutic substance is delivered to the body of the patient, during delivery of the therapeutic substance to the body of the patient, and after the therapeutic substance has been delivered to the body of the patient.

3. The device according to claim 1 , wherein the substance delivery device is a delivery pump.

4. The device according to claim 1 , wherein the treatment element is configured to apply treatment in order to perform at least one of the functions selected from a group consisting of: enabling a faster onset of action of the therapeutic substance infused into the infused region, enabling a faster peak of action of the therapeutic substance infused into the infused region, enabling a faster clearance of the therapeutic substance from the infused region and into a circulatory system of the patient, improving the repeatability of the pharmacokinetic and/or pharmacodynamic profile in response to the infusion of the therapeutic substance, reducing a variability of absorption of the therapeutic substance into the blood system and/or lymphatic system of the patent, reducing a variability of onset of action of the therapeutic substance, reducing a variability of time to peak of action of the therapeutic substance, and reducing a variability of the clearance of the therapeutic substance from the infused region and into the circulatory system of the patient.

5. The device according to claim 1 , wherein the substance is configured to be injected subcutaneously and further configured to have a systemic effect.

6. The device according to claim 3 , wherein the therapeutic substance is selected from a group consisting of: insulin, insulin analogues, and insulin mimetics.

7. The device according to claim 1 , wherein the treatment element is further configured to modify blood perfusion in the vicinity of the infused region.

8. The device according to claim 6 , wherein the treatment element is a heater configured to modify a temperature of the bodily tissue in the vicinity of the infused region;

wherein the heater does not heat the therapeutic substance above a limiting temperature.

9. The device according to claim 6 , wherein the treatment element is configured to heat the skin of the patient in the vicinity of the infused region to a temperature in a range of 37-39° C. for a predetermined period of time after bolus infusion initiation.

10. The device according to claim 9 , wherein the insulin is a rapid acting insulin.

11. The device according to claim 10 , wherein insulin is infused into the patient using long period bolus mode, such as square or split bolus mode, to adjust the insulin pharmacokinetics and/or pharmacodynamics.

12. The device according to claim 10 , wherein insulin is infused into the patient using fast bolus mode.

13. The device according to claim 9 , wherein insulin is a regular insulin.

14. The device according to claim 6 , wherein the sensor is configured to detect an infusion of an insulin bolus.

15. The device according to claim 14 , wherein the sensor includes an electromagnetic sensing element for measuring an electromagnetic emission of the delivery pump.

16. The device according to claim 3 , wherein the controller unit is disposed inside the delivery pump.

17. The device according to claim 8 , wherein the housing further includes a reservoir containing the therapeutic substance and an infusion tube, and is configured to enclose the treatment element along with the substance delivery device and the reservoir;

wherein the treatment element is configured to apply heat in the vicinity of the infused region without heating the reservoir and the infusion tube above the limiting temperature.

18. The device according to claim 1 , wherein the substance delivery device is disposable.

19. The device according to claim 1 , wherein the treatment element is disposed in the catheter securing element.

20. The device according to claim 1 , wherein the treatment element includes a heater and is configured to regulate heating of the infused region to stabilize its temperature at a pre-determined temperature in order to stabilize pharmacokinetics of the infused therapeutic substance.

21. The device according to claim 1 , wherein the applied treatment is selected from a group consisting of: heating, cooling, intermittent temperature change, optical radiation, micro-wave, radio frequency, electromagnetic radiation, vibration device, physical stimulation, massage the infused region, suction, vacuum, electric field, magnetic field, acoustic signal, ultrasound, and application of one more additional substances to modify the infused substance pharmacokinetics, and/or a combination of at least two of the above treatments.

22. A method for delivering a therapeutic substance into the body of a patient, the method comprising the steps of:

providing a device for delivering the therapeutic substance into the body of the patient having

an infusion catheter;

a catheter securing element;

a housing including

a substance delivery device;

a sensor built into the housing and configured to detect infusion of the therapeutic substance;

a treatment element; and

a controller unit in communication with the treatment element;

adhering the catheter securing element to the skin of the patient and securing the infusion catheter to the skin of the patient;

inserting the infusion catheter into a bodily tissue disposed at an insertion site located on the body of the patient;

using the substance delivery device, infusing the therapeutic substance into the infusion catheter;

using the infusion catheter, delivering the therapeutic substance into the body of the patient to an infused region, wherein the infused region includes a volume of the bodily tissue surrounding the insertion site;

using the controller unit, initiating application of the treatment by the treatment element upon detecting beginning of the infusion of the therapeutic substance;

using the treatment element, applying the treatment in a vicinity of the infused region; and

modifying a pharmacokinetic and/or pharmacodynamic profile of the infused therapeutic substance.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 6, 2013
From: PESACH, BENNY, MR.; NAGAR, RON, MR.; BITTON, GABRIEL, MS.; WEISS, RAM, MR.
To: INSULINE MEDICAL LTD.
Reel/Frame 031149/0184 →
Continuity (12)
Continuation In Part 11821230 · Jun 21, 2007
Provisional Application 60895518 · Mar 19, 2007
Provisional Application 60895519 · Mar 19, 2007
Provisional Application 60912698 · Apr 19, 2007
Provisional Application 60940721 · May 30, 2007
Provisional Application 61008278 · Dec 18, 2007
Provisional Application 60956700 · Aug 19, 2007
Provisional Application 60970997 · Sep 10, 2007
Provisional Application 61008325 · Dec 18, 2007
Provisional Application 61008274 · Dec 18, 2007
Provisional Application 61008277 · Dec 18, 2007
Related Publication 20100152644A1 · Jun 17, 2010